
Empowering Immunotherapy Companion Diagnostics
Precise.Validated TMB Reference Standards for tissue and liquid biopsy assays
Product Center
CBP80001-1/2/3/4/5/6/7/8
CBP80001-1/2/3/4/5/6/7/8

Product Introduce
Tumor Mutational Burden (TMB) Reference Standards
TMB measures the number of somatic mutations per megabase of the tumor genome. It is a validated pan-cancer biomarker for immune checkpoint inhibitor response (FDA-approved for TMB-H ≥10 mut/Mb).
CB-Gene’s TMB diagnostic reference standards are designed to help IVD developers and clinical labs accurately assess the limit of detection, linearity, and reproducibility of their TMB assays. Our portfolio includes tissue-simulating (tTMB) and blood-based (bTMB) standards, with TMB scores ranging from 5.37 to 27.15 mut/Mb – including critical values around the 10 mut/Mb clinical cutoff.
Product Advantages
Precisely quantify tumor mutational burden with our complete panel of tissue and blood-based reference standards. Validated by WES, covering a full TMB range (5–27 mut/Mb) to support assay development, regulatory submission, and routine quality control.
Gold-standard validation
TMB scores derived from whole-exome sequencing (WES) compared to matched normal samples.
Wide gradient coverage
Low, medium, and high TMB values (5.37, 8.98, 9.84, 12.41, 21.09, 22.91, 27.15 mut/Mb) for linearity and accuracy studies.
tTMB & bTMB formats
Both tissue-mimicking reference standards and circulating tumor DNA (ctDNA) blood-based standards.
Limit-of-detection assessment
Available with different tumor content percentages and allele frequency (AF) cutoffs.
Matrix control
Negative/matrix standard (CBP80001-9) for background evaluation.

Application
IVD Kit Development & Performance Verification
Testing Sensitivity, Accuracy & Specificity of Experimental Methods
Daily QC Monitoring of NGS Library Preparation & Sequencing Runs
Company Advantage
We stands out with a strong foundation in precision diagnostics and a commitment to high-quality, reliable products
Scientific Quality Management
With our ISO9001 certification, we adhere to a stringent quality management system, ensuring that all our products meet the highest standards of accuracy, stability, and consistency.
Experienced and Skilled Team
Backed by a talented team of experts, we leverage advanced technology and extensive experience to drive innovation in molecular diagnostics, ensuring we stay at the forefront of the industry.
Advanced Laboratories
Our lean laboratories, located in Shanghai and Nanjing, China, are equipped to provide continuous and stable high-quality products, supporting both large-scale production and personalized customer needs.
Comprehensive Product Range
We offer a complete set of reference materials, including SNP, Indel, CNV, Fusion, NIPT, and more, covering a wide array of diagnostic needs and offering customized services for a variety of applications.

Contact Us
We're here to assist you! Whether you have questions about our products, services, or need technical support, our team is ready to provide you with the information you need. Reach out to us today!
FAQs
Related Blogs
Understanding NIPT Research: The Role of Reference Standards in Enhancing Testing Accuracy
In the rapid evolution of prenatal genomics, non-invasive prenatal testing (NIPT) has emerged as one of the most groundbreaking advancements. It enables fetal chromosomal screening through maternal blood sampling and analysis of cell-free DNA (cfDNA).
Read MoreFetal Fraction Matters: Enhancing NIPT Assay Performance with Matched Reference Materials
Fetal fraction (FF)—the percentage of cell-free fetal DNA in maternal plasma—is a critical factor affecting the sensitivity and reliability of non-invasive prenatal testing (NIPT).
Read MoreOptimizing Cancer Genomic Testing with HRD Reference Standards: A Focus on Precision and Quality
In the field of cancer genomics research, ensuring accurate and reproducible results is critical for the development and validation of high-performance assays. As genomic technologies such as Next-Generation Sequencing (NGS) continue to evolve, the demand for reliable and standardized reference materials has grown.
Read MoreUnderstanding HRD and its Role in Cancer Detection: A Guide for Genomic Testing Companies
Homologous Recombination Deficiency (HRD) refers to a condition where a cell's ability to repair DNA double-strand breaks via the homologous recombination repair (HRR) pathway is compromised. This deficiency can lead to genomic instability, a hallmark of many cancer types.
Read More
Get Touch With Us

Contact Info
Have questions or need assistance? We're here to help! Reach out to our team, and we'll provide the support you need.


